Brivaracetam
Catalog No: 16122906
CAS Number: 357336-20-0
Purity: 98%
Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle glycoprotein 2A (SV2A), like levetiracetam. SV2A plays a role in exocytosis of various neurotransmitters. Brivaracetam was approved to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs.
For research use only. We do not sell to patients.
Chemical Information
| Name | Brivaracetam |
|---|---|
| Iupac Chemical Name | (S)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide |
| Synonyms | UCB 34714 ; UCB-34714 ; UCB34714 ; Briviact ; Brivaracetam |
| Molecular Formula | C11H20N2O2 |
| Molecular Weight | 212.293 |
| Smile | CC[C@H](N1C(C[C@@H](CCC)C1)=O)C(N)=O |
| InChiKey | MSYKRHVOOPPJKU-BDAKNGLRSA-N |
| InChi | InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1 |
| CAS Number | 357336-20-0 |
| MDL | MFCD13152385 |
| Related CAS | 357336-20-0 |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
